Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,882 | 163 | 94.5% |
| Education | $167.32 | 8 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $507.06 | 30 | $0 (2021) |
| Allergan, Inc. | $196.30 | 14 | $0 (2021) |
| Amgen Inc. | $191.96 | 13 | $0 (2021) |
| Medtronic USA, Inc. | $183.11 | 7 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $145.12 | 9 | $0 (2020) |
| AbbVie, Inc. | $138.08 | 10 | $0 (2019) |
| Cogentix Medical Inc. | $120.64 | 1 | $0 (2017) |
| PFIZER INC. | $109.72 | 8 | $0 (2020) |
| Axonics, Inc. | $94.66 | 4 | $0 (2022) |
| NeoTract Inc. | $91.75 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.04 | 2 | BLUEWIND MEDICAL ($22.10) |
| 2023 | $16.77 | 1 | C. R. Bard, Inc. & Subsidiaries ($16.77) |
| 2022 | $64.07 | 2 | Axonics, Inc. ($49.16) |
| 2021 | $426.06 | 28 | Myovant Sciences Inc. ($54.38) |
| 2020 | $115.02 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($34.67) |
| 2019 | $552.67 | 31 | Astellas Pharma US Inc ($100.09) |
| 2018 | $681.39 | 46 | Astellas Pharma US Inc ($134.95) |
| 2017 | $1,156 | 53 | Astellas Pharma US Inc ($231.43) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: UROLOGY | ||||||
| 02/08/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: BLADDER | ||||||
| 11/09/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Urology | ||||||
| 12/09/2022 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $49.16 | General |
| Category: Urology | ||||||
| 02/03/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: Urology | ||||||
| 12/14/2021 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Urology Gynecology | ||||||
| 12/09/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Urology | ||||||
| 12/07/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 11/08/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/04/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 10/26/2021 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Urology | ||||||
| 10/07/2021 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Prostate cancer | ||||||
| 10/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: UROLOGY | ||||||
| 10/04/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2021 | Axonics, Inc. | Bulkamid (Device), Axonics r-SNM System | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Urology | ||||||
| 09/10/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/08/2021 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 09/07/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: HORMONE THERAPY | ||||||
| 07/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: UROLOGY | ||||||
| 06/24/2021 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/23/2021 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Oncology | ||||||
| 06/02/2021 | Axonics, Inc. | Axonics r-SNM System (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Urology | ||||||
| 05/17/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2021 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 04/14/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 4,135 | 6,762 | $814,347 | $236,376 |
| 2022 | 31 | 3,298 | 4,790 | $881,257 | $242,903 |
| 2021 | 22 | 2,228 | 3,479 | $786,645 | $200,970 |
| 2020 | 18 | 1,886 | 3,128 | $608,655 | $148,472 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 433 | 698 | $131,224 | $49,372 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 421 | $115,492 | $44,370 | 38.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 24 | 173 | $75,881 | $22,909 | 30.2% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 352 | 513 | $86,184 | $20,258 | 23.5% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 145 | 158 | $61,462 | $14,424 | 23.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 136 | 154 | $58,872 | $14,411 | 24.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 48 | 49 | $43,610 | $10,429 | 23.9% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 487 | 899 | $29,667 | $7,064 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $22,660 | $6,731 | 29.7% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 252 | 365 | $27,740 | $6,490 | 23.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 249 | 362 | $27,512 | $6,469 | 23.5% |
| 87088 | Bacterial urine culture | Office | 2023 | 430 | 763 | $25,942 | $6,011 | 23.2% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 18 | 19 | $21,717 | $5,517 | 25.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 276 | 414 | $6,210 | $3,461 | 55.7% |
| 53661 | Subsequent dilation of urethra in female | Office | 2023 | 34 | 51 | $17,850 | $3,169 | 17.8% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 54 | 64 | $12,864 | $2,956 | 23.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 524 | 1,008 | $10,080 | $2,207 | 21.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,480 | $1,888 | 34.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 63 | $7,623 | $1,827 | 24.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 101 | 182 | $2,353 | $1,539 | 65.4% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 98 | 173 | $5,709 | $1,370 | 24.0% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 37 | 53 | $5,618 | $1,315 | 23.4% |
| 53660 | Initial dilation of urethra in female | Office | 2023 | 16 | 16 | $7,200 | $1,036 | 14.4% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 29 | 40 | $3,240 | $852.00 | 26.3% |
| 82040 | Albumin (protein) level | Office | 2023 | 28 | 37 | $777.00 | $179.45 | 23.1% |
About Dr. Gary Wasserman, MD
Dr. Gary Wasserman, MD is a Urology healthcare provider based in Cliffside Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518049832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Wasserman, MD has received a total of $3,049 in payments from pharmaceutical and medical device companies, with $37.04 received in 2024. These payments were reported across 171 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($2,882).
As a Medicare-enrolled provider, Wasserman has provided services to 11,547 Medicare beneficiaries, totaling 18,159 services with total Medicare billing of $828,722. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Cliffside Park, NJ
- Active Since 10/19/2006
- Last Updated 03/07/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1518049832
Products in Payments
- XTANDI (Drug) $363.73
- INTERSTIM (Device) $183.11
- Prolia (Biological) $139.87
- Androgel (Drug) $123.08
- Urgent PC (Device) $120.64
- MYRBETRIQ (Drug) $104.34
- Xtandi (Drug) $103.65
- FIRMAGON (Drug) $103.23
- Myrbetriq (Drug) $101.83
- Urolift - UL400 (Device) $91.75
- BOTOX THERAPEUTIC (Biological) $88.45
- CONTINENCE CARE (Device) $73.33
- PROVENGE (Drug) $68.78
- Bulkamid (Device) $68.18
- XIAFLEX (Biological) $66.62
- Nubeqa (Drug) $54.67
- Noctiva (Drug) $54.38
- ORGOVYX (Drug) $54.38
- BOTOX OAB (Drug) $54.32
- BOTOX (Biological) $53.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.